Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Use of Chemotherapy in the Management of Hormone-Sensitive Metastatic Prostate Cancer

To see the complete question and investigator responses, move your mouse over the related topic.
Click the "Select Faculty Commentary" button to review full commentary (login required).

*Please refer to individual commentary for treatment preferences in relation to bone-targeted therapy.